Picture of Biorestorative Therapies logo

BRTX — Biorestorative Therapies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: BioRestorative, Galen Patient Recruitment Partner To Accelerate Enrollment Completion In Mid-Stage Trial of Therapy To Treat Chronic Lumbar Disc Disease

April 8 (Reuters) - BioRestorative Therapies Inc
 BRTX.O :
    * BIORESTORATIVE THERAPIES PARTNERS WITH GALEN PATIENT
RECRUITMENT
TO ACCELERATE COMPLETION OF ENROLLMENT IN PHASE 2 TRIAL OF
BRTX-100 IN CHRONIC LUMBAR DISC DISEASE
    * BIORESTORATIVE THERAPIES INC - PATIENT ENROLLMENT EXPECTED
TO BE
COMPLETED IN 2024

Source text for Eikon:  ID:nGNX5tmHlV 
Further company coverage:  BRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Biorestorative Therapies

See all news